Disclosure 0001995218-26-000015-1

SEC FORM 4

$16,561.76

Lexeo Therapeutics, Inc. (LXEO)

Sale of 3,345 shares at $4.9512 per share.

Reporting Person Townsend Richard Nolan · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001995218-26-000015 · filed 2026-08-19 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Lexeo Therapeutics, Inc. (LXEO)." Disclosed 2026-08-19. https://desqlong.com/cards/0001995218-26-000015-1 (retrieved 2026-09-26).